VIRUCIDAL TREATMENT OF CLOTTING FACTOR CONCENTRATES

This publication has 10 references indexed in Scilit:

• VIRUS SAFETY OF SOLVENT/DETERGENT-TREATED ANTIHAEMOPHILIC FACTOR CONCENTRATE
  The Lancet, 1988
• Reduced risk of non‐A, non‐B hepatitis after a first exposure to ‘wet heated’factor VIII concentrate
  British Journal of Haematology, 1987
• Assessment for evidence of non a-non b hepatitis in patients given n-heptane-suspended heat-treated clotting factor concentrates
  Thrombosis Research, 1987
• Absence of Hepatitis after Treatment with a Pasteurized Factor VIII Concentrate in Patients with Hemophilia and No Previous Transfusions
  New England Journal of Medicine, 1987
• No Hepatitis After Treatment with a Modified Factor IX Concentrate in Previously Untreated Hemophiliacs
  Annals of Internal Medicine, 1985
• TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATE
  The Lancet, 1985
• High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin
  British Journal of Haematology, 1985
• Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.
  BMJ, 1983
• If nothing goes wrong, is everything all right? Interpreting zero numerators
  Published by American Medical Association (AMA) ,1983
• Clinical evaluation of the hepatitis safety of a β-propiolactone/ultraviolet treated factor IX concentrate (PPSB)
  Thrombosis Research, 1982